INTU vs PFE: Which Is the Better Buy?
Side-by-side comparison of Intuit Inc. and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-11.
Intuit Inc. · Technology
$396.57
+37.7% upside to fair value
High Conviction
Grade A-
VS
Pfizer Inc. · Healthcare
$26.91
+30.1% upside to fair value
Med Conviction
Grade B+
QuantHub Verdict
INTU has more upside to fair value
(+37.7%).
PFE trades at a lower forward P/E
(9.5x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
INTU |
PFE |
| Current Price |
$396.57 |
$26.91 |
| Fair Value Estimate |
$546.00 |
$35.00 |
| Upside to Fair Value |
+37.7%
|
+30.1%
|
| Market Cap |
$110.4B |
$153.0B |
| Forward P/E |
19.5x
|
9.5x
|
| EV / EBITDA |
19.0x
|
13.8x
|
| Price / Sales |
5.9x
|
2.4x
|
| Price / FCF |
18.1x
|
16.8x
|
| Revenue Growth YoY |
+15.6%
|
-1.6%
|
| Gross Margin |
80.8%
|
70.3%
|
| Operating Margin |
26.1%
|
24.7%
|
| Return on Equity |
19.6%
|
9.0%
|
| Dividend Yield |
1.17% |
6.4% |
| FCF Yield |
5.51%
|
5.9%
|
| Analyst Consensus |
Buy
|
Hold
|
Investment Thesis
Intuit is a near-monopoly financial operating system for 60+ million American households and small businesses. TurboTax handles 40%+ of US e-filed returns; QuickBooks is so deeply embedded in SMB workflows it has become the default accounting standard. The stock has fallen 51% from its 2025 high as markets price in AI disruption that has not materialized at scale and may not, since tax complexity…
Pfizer remains the world's largest traditional pharmaceutical company by non-COVID revenue, generating $62.6B in 2025 sales across oncology, cardiovascular, immunology, and vaccines. The stock trades at a P/S of 2.44x, still well below the 5-year median of 3.10x, driven by post-COVID revenue normalization, a $17-18B patent cliff spanning 2026-2028, and $61.6B in acquisition-related debt from Seag…
Accumulation Zones
| Metric |
INTU |
PFE |
| Zone Low |
$410.00 |
$25.00 |
| Zone High |
$464.00 |
$29.00 |
| In Buy Zone? |
Yes
|
Yes
|